Sublethal oligodendrocyte injury: A reversible condition in multiple sclerosis?

Qiao Ling Cui, Damla Khan, Malena Rone, Vijayaraghava T.S. Rao, Radia Marie Johnson, Yun Hsuan Lin, Philippe Antoine Bilodeau, Jeffery A. Hall, Moses Rodriguez, Timothy E. Kennedy, Samuel K. Ludwin, Jack P. Antel

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Objective: Degeneration of oligodendroglial distal processes has been identified as an early event in multiple sclerosis (MS) lesion development. Our objective was to further define the development of the “dying-back” oligodendrocyte lesion in situ and to model the development and potential reversibility of such responses using dissociated cultures of adult human brain-derived oligodendrocytes. Methods: In situ analyses were performed on glutaraldehyde-fixed thin sections of clinically acute and pathologically active cases of MS. In vitro studies were conducted using adult human brain-derived oligodendrocytes challenged by metabolic stress conditions (low nutrient/glucose). Results: In situ analyses indicated a spectrum of myelin changes in the presence of morphologically intact oligodendrocytes; these included degeneration of the inner cytoplasmic tongue with increasing sizes of intramyelinic bleb formation that could result in radial fractures of the myelin sheath. Macrophages with ingested myelin fragments were identified only once the fragmentation was established. In vitro studies indicated that oligodendrocyte process retraction, which was linked to reduced glycolytic respiratory activity, is reversible until a critical time point. Subsequent cell death was not linked to caspase-3–dependent programs. Gene expression studies conducted at the latest reversible time point revealed reduced expression of pathways associated with cell process outgrowth and myelination, as well as with metabolic activity. Interpretation: Our findings reveal the potential to protect and possibly restore myelin elaborated by existent oligodendrocytes in early and evolving MS lesions, and suggest the necessity of ongoing studies of the mechanisms underlying subsequent adult human oligodendrocyte cell death. Ann Neurol 2017;81:811–824.

Original languageEnglish (US)
Pages (from-to)811-824
Number of pages14
JournalAnnals of Neurology
Volume81
Issue number6
DOIs
StatePublished - Jun 1 2017

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Sublethal oligodendrocyte injury: A reversible condition in multiple sclerosis?'. Together they form a unique fingerprint.

  • Cite this

    Cui, Q. L., Khan, D., Rone, M., T.S. Rao, V., Johnson, R. M., Lin, Y. H., Bilodeau, P. A., Hall, J. A., Rodriguez, M., Kennedy, T. E., Ludwin, S. K., & Antel, J. P. (2017). Sublethal oligodendrocyte injury: A reversible condition in multiple sclerosis? Annals of Neurology, 81(6), 811-824. https://doi.org/10.1002/ana.24944